Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.

@article{Atsuta2014ContinuingIR,
  title={Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.},
  author={Yoshiko Atsuta and Ritsuro Suzuki and Takuya Yamashita and Takahiro Fukuda and Koichi Miyamura and Shuichi Taniguchi and Hiroatsu Iida and Toshiki Uchida and Kazuhiro Ikegame and Satoshi Takahashi and Koji Kato and Keisei Kawa and Tokiko Nagamura-Inoue and Yasuo Morishima and Hisashi Sakamaki and Yoshihisa Kodera},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2014},
  volume={25 2},
  pages={435-41}
}
BACKGROUND The number of long-term survivors after hematopoietic stem cell transplantation (HSCT) showed steady increase in the past two decades. Second malignancies after HSCT are a devastating late complication. We analyzed the incidence of, risk compared with that in the general population, and risk factors for secondary solid cancers. PATIENTS AND METHODS Patients were 17 545 adult recipients of a first allogeneic stem cell transplantation between 1990 and 2007 in Japan. Risks of… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 4 times over the past 90 days. VIEW TWEETS